Skip to content

ScienceIsomorphic Labs

Isomorphic Labs

AI-first drug design built on AlphaFold for pharma R&D.

Category
Science
Pricing
PAID
Source
Proprietary
Hosting
Cloud
Platforms
Web
Verified
Jun 14, 2026

Isomorphic Labs is an AI-first drug discovery company spun out of Google DeepMind, building generative and predictive ML models for molecular design and drug-performance prediction. Its Drug Design Engine builds on AlphaFold to advance internal and partnered pipelines with Eli Lilly, Novartis, and J&J. It is a drug-discovery company that works through pharma R&D partnerships rather than a self-serve product.

Capabilities 2

What it actually does — grouped by capability family.

  • Protein structure prediction (primary capability)
  • Molecular design (secondary capability)

Pros & cons

  • AlphaFold-derived design models
  • Alphabet-backed capital
  • Top-pharma partnerships
  • Nobel-laureate leadership
  • Pharma partnerships only
  • No public product or API
  • No approved drug yet
  • Opaque pricing

Tags

Further reading

Alternatives to Isomorphic Labs (3)

View all Science →
  • View Chai Discovery details
    ScienceFREEMIUMOpen core

    Chai Discovery

    Chai Discovery

    Foundation models for molecular structure and antibody design.

    Chai Discovery builds foundation models for drug discovery — Chai-1 for biomolecular structure prediction across proteins, ligands, DNA/RNA, and glycans, and Chai-2 for de novo antibody design. Chai-1 weights and inference code are released for non-commercial use, and a free web server runs the model in-browser. It is both a model provider and a usable platform.

    Free in-browser structure prediction
    Weights non-commercial only
    • protein-structure
    • antibody-design
    • drug-discovery
    • open-weights
    Open
  • View Profluent details
    SciencePAID

    Profluent

    Profluent Bio

    Generative protein language models that design novel proteins.

    Profluent uses generative AI — its ProGen-lineage protein language models — to author novel proteins from scratch or from natural scaffolds, for medicine and agriculture. It open-released and published OpenCRISPR-1 in Nature, and is expanding into antibodies and enzymes. It operates as an AI protein-design company working through partnerships with open-sequence releases, not a self-serve consumer platform.

    ProGen protein-LLM lineage
    Partnership/licensing only
    • protein-design
    • gene-editing
    • drug-discovery
    • biotech
    Open
  • View Lila Sciences details
    SciencePAID

    Lila Sciences

    Lila Sciences

    Autonomous AI labs pursuing scientific superintelligence.

    Lila Sciences is building a 'scientific superintelligence' platform that pairs a proprietary AI model with autonomous AI Science Factory lab instruments to generate hypotheses, design and run experiments, and learn in real time. It offers Catalyst, which augments existing R&D, and Creation, for new discoveries, across materials, therapeutics, chemicals, and energy. It is a platform and research company engaged through partnership rather than self-serve.

    Autonomous experiment loop
    Partnership-only engagement
    • autonomous-lab
    • materials
    • drug-discovery
    • scientific-ai
    Open
Open Isomorphic Labs